Lv0
0 积分 2025-12-09 加入
REAL-WORLD BIOLOGICS USE IN EUROPEAN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): CHARACTERISTICS AND OUTCOMES
5个月前
已完结
Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis
5个月前
已完结
Expert consensus on the multidisciplinary management of patients with heart failure and chronic obstructive pulmonary disease
5个月前
已完结
Adverse Effects of Dupilumab for Chronic Rhinosinusitis With Nasal Polyposis: Real‐World Single Institution Experience
5个月前
已完结
Discussing Digital Interventions in Asthma Symptom Monitoring
5个月前
已关闭
4-Week Maintenance ICS-Formoterol versus ICS in Adults Newly Diagnosed Mild Asthma: Effects on Symptoms, Lung Function, and Inflammation
5个月前
已关闭
Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond
6个月前
已完结
Role of thymic stromal lymphopoietin in allergy and beyond
6个月前
已完结
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
6个月前
已完结
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
6个月前
已完结
皖公网安备34019202002308
